A podcast on medicine, oncology, & health policy. Host: Vinay Prasad, MD MPH from University of California San Francisco. Tweet your feedback to @Plenary_Session or e-mail plenarysessionpodcast@gmail.com
…
continue reading
Screening/ Drug efficacy/ Sotorasib/ Adaura and moreΑπό τον Plenary Session
…
continue reading
My UCSF lecture on driver mutation lung cancerΑπό τον Plenary Session
…
continue reading
We break down the best studies from ASCOΑπό τον Plenary Session
…
continue reading
1
Critical Appraisal - My 2 hour ASCO lecture - Day 2 version
1:54:09
1:54:09
Αναπαραγωγή αργότερα
Αναπαραγωγή αργότερα
Λίστες
Like
Liked
1:54:09
Critical Appraisal - My 2 hour ASCO lecture - Day 2 version by Plenary SessionΑπό τον Plenary Session
…
continue reading
What you need to know in advance of ASCOΑπό τον Plenary Session
…
continue reading
Should trials have carbon footprint as an endpoint?Από τον Plenary Session
…
continue reading
My grand rounds; Beta blockers post MISingle center vs multicenter RCTMasksBoosters and moreΑπό τον Plenary Session
…
continue reading
I crossover SM podcast; Harvard med students video, Justice curriculum, Masking half the yearΑπό τον Plenary Session
…
continue reading
Patient advocates, Pharma funding, and is MRD a suitable endpointΑπό τον Plenary Session
…
continue reading
5 reasons that is a bad ideaΑπό τον Plenary Session
…
continue reading
Another flawed quality metric. Reviewing the NEJM paper "Beta-Blockers After Myocardial Infarction and Preserved Ejection Fraction".Από τον Plenary Session
…
continue reading
They are shittyΑπό τον Plenary Session
…
continue reading
Another flawed study Keynote 564. Pembro in adjuvant RCCΑπό τον Plenary Session
…
continue reading
What happens when doctors run unethical studies?Από τον Plenary Session
…
continue reading
Does car T cause secondary AML?We discussΑπό τον Plenary Session
…
continue reading
We talk about 2023 cancer trialsΑπό τον Plenary Session
…
continue reading
Goodman and I discuss ash updates.My myeloma talkhttps://www.youtube.com/watch?v=jAz84yCnfjQΑπό τον Plenary Session
…
continue reading